# Enhancers in T Cell development and malignant lesions

## TL;DR

This paper reviews how enhancers influence T cell development and how they may contribute to T cell cancers, suggesting new drug targets.

## Contribution

The paper proposes that specific Mediator complex subunits could be targeted to treat T cell malignancies.

## Key findings

- Enhancers regulate key genes in T cell development.
- Dysfunctional enhancers may contribute to T cell malignancies.
- Targeting Mediator complex subunits could disrupt cancer-related enhancers.

## Abstract

Enhancers constitute a vital category of cis-regulatory elements with a Mediator complex within DNA sequences, orchestrating gene expression by activating promoters. In the development of T cells, some enhancers regulate the critical genes, which might also regulate T cell malignant lesions. This review is to comprehensively elucidate the contributions of enhancers in both normal T cell development and its malignant pathogenesis, proposing the idea that the precise subunits of the Mediator complex are the potential drug target for disrupting the specific gene enhancer for T cell malignant diseases.